These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 17498782

  • 1. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
    Lentz SS, Miller BE, Kucera GL, Levine EA.
    Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.
    Bae JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, Ahn WS, Namkoong SE.
    Gynecol Oncol; 2007 Jul; 106(1):193-200. PubMed ID: 17466362
    [Abstract] [Full Text] [Related]

  • 3. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
    Helm CW, Randall-Whitis L, Martin RS, Metzinger DS, Gordinier ME, Parker LP, Edwards RP.
    Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
    [Abstract] [Full Text] [Related]

  • 4. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.
    Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM.
    Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up.
    Yoshida Y, Sasaki H, Kurokawa T, Kawahara K, Shukunami K, Katayama K, Yamaguchi A, Kotsuji F.
    Oncol Rep; 2005 Jan; 13(1):121-5. PubMed ID: 15583812
    [Abstract] [Full Text] [Related]

  • 6. Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study.
    Argenta PA, Sueblinvong T, Geller MA, Jonson AL, Downs LS, Carson LF, Ivy JJ, Judson PL.
    Gynecol Oncol; 2013 Apr; 129(1):81-5. PubMed ID: 23352917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T.
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis.
    Bristow RE, Chi DS.
    Gynecol Oncol; 2006 Dec; 103(3):1070-6. PubMed ID: 16875720
    [Abstract] [Full Text] [Related]

  • 15. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer.
    Steller MA, Egorin MJ, Trimble EL, Bartlett DL, Zuhowski EG, Alexander HR, Dedrick RL.
    Cancer Chemother Pharmacol; 1999 Dec; 43(2):106-14. PubMed ID: 9923815
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma.
    Kimball KJ, Numnum TM, Kirby TO, Zamboni WC, Estes JM, Barnes MN, Matei DE, Koch KM, Alvarez RD.
    Gynecol Oncol; 2008 Oct; 111(1):95-101. PubMed ID: 18692224
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
    Fader AN, von Gruenigen V, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose P.
    Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784
    [Abstract] [Full Text] [Related]

  • 19. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
    Atmaca A, Al-Batran SE, Neumann A, Kolassa Y, Jäger D, Knuth A, Jäger E.
    Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
    [Abstract] [Full Text] [Related]

  • 20. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
    Matulonis UA, Krag KJ, Krasner CN, Atkinson T, Horowitz NS, Lee H, Penson RT.
    Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.